BackgroundSystemic hypertension may be associated with an increased pulmonary vascular resistance, which we hypothesized could be, at least in part, mediated by increased leptin.MethodsVascular reactivity to phenylephrine (1 μmol/L), endothelin-1 (10 nmol/L) and leptin (0.001–100 nmol/L) was evaluated in endothelium-intact and -denuded isolated thoracic aorta and pulmonary arteries from spontaneously hypertensive versus control Wistar rats. Arteries were sampled for pathobiological evaluation and lung tissue for morphometric evaluation.ResultsIn control rats, endothelin-1 induced a higher level of contraction in the pulmonary artery than in the aorta. After phenylephrine or endothelin-1 precontraction, leptin relaxed intact pulmonary artery and aortic rings, while no response was observed in denuded arteries. Spontaneously hypertensive rats presented with increased reactivity to phenylephrine and endothelin-1 in endothelium-intact pulmonary arteries. After endothelin-1 precontraction, endothelium-dependent relaxation to leptin was impaired in pulmonary arteries from hypertensive rats. In both strains of rats, aortic segments were more responsive to leptin than pulmonary artery. In hypertensive rats, pulmonary arteries exhibited increased pulmonary artery medial thickness, associated with increased expressions of preproendothelin-1, endothelin-1 receptors type A and B, inducible nitric oxide synthase and decreased endothelial nitric oxide synthase, together with decreased leptin receptor and increased suppressor of cytokine signaling 3 expressions.ConclusionsAltered pulmonary vascular reactivity in hypertension may be related to a loss of endothelial buffering of vasoconstriction and decreased leptin-induced vasodilation in conditions of increased endothelin-1.
Although in vitro exposure to DEP produces a vascular oxidative stress, repeated in vivo exposures to DEP only impair vascular function in SHR, via an upregulation of p22phox. This suggests a synergistic effect on endothelial dysfunction between particulate air pollution and hypertension.
Decreased leptin-induced endothelium-dependent vasodilation has been reported in spontaneously hypertensive rats (SHR). Here, we report leptin-induced vasoconstriction in endothelium-denuded pulmonary artery and thoracic aorta from SHR and sought to characterize calcium handling underlying these mechanisms. Vasoreactivity to leptin was evaluated on pulmonary artery and thoracic aorta rings from 18 weeks old male SHR with or without calcium free medium, caffeine + thapsigargin + carbonyl cyanide-4-trifluoromethoxyphenylhydrazone emptying intracellular calcium stores, nifedipine a voltage-gated calcium channel inhibitor, SKF-96365 a transient receptor potential cation channels (TRPC) inhibitor, wortmaninn, a phosphatidylinositide 3-kinases (PI3K) inhibitor, or PD98059 a mitogen-activated protein kinase kinase (MAPKK) inhibitor. Calcium imaging was performed on cultured vascular smooth muscle cells incubated with leptin in presence or not of wortmaninn or PD98059. Leptin induced vasoconstriction in denuded pulmonary artery and thoracic aorta from SHR. Response was abolished when intra- or extracellular calcium stores were emptied, after blocking TRPC or voltage-dependent calcium channels or when using MAPKK or PI3K inhibitors. In vascular smooth muscle cells, leptin increased intracellular calcium. This rise was higher in SHR and abolished by MAPKK or PI3K inhibitors. TRPC6 gene expression was upregulated in arteries from SHR. Leptin-induced vasoconstriction in denuded arteries of SHR requires intracellular stores and is TRPC- and voltage-gated calcium channels dependent. Intracellular calcium increase is more pronounced in spontaneously hypertensive rats.
Introduction and Aims: Aristolochic acid nephropathy is characterized not only by marked tubular atrophy and interstitial fibrosis but also by severe peritubular capillaries rarefaction. Human umbilical vein endothelial cells (HUVECs) and rat aortic rings were then used to assess the possible vascular toxicity of aristolochic acid (AA). Methods: HUVECs were incubated during 48h with or without AA (50 or 100 µM). Cell viability was measured by MTT assay. The number of nuclei was counted by DAPI. Pecam adhesion molecule (CD31) cell expression was analyzed by immunofluorescence. We studied the endothelium-dependent relaxations to acetylcholine (ACh) in rat aortas incubated for 1h with 200 µM AA, in the presence or in the absence of superoxide dismutase (SOD). Endothelium independent relaxations to sodium nitroprusside (SNP) were also tested on preparations after endothelium denudation. Results: AA exposure resulted in a significant decrease in the total count of cells which exhibited a typical spindle shape (CD31+ cells/ total count [%] vs controls [100%]: 60.27 ± 13.50 with AA 50 µM and 53.70 ± 8.82 with AA 100 µM, respectively). The MTT assay showed a dose-dependent toxicity of AA (cell viability [%] vs controls [100%]: 70.26 ± 4.80 with AA 50 µM and 12.50 ± 3.26 with AA 100 µM, respectively). ACh-induced relaxations were significantly impaired in rat aortic rings pre-incubated with AA 200 µM: the AUC was 170.9 ± 8.9 in control conditions vs 236.0 ± 8.7 in rings incubated with AA ( p < 0.0001). This effect was reversed after washing of the aortic rings or in the presence of SOD (200 UI). The toxicity was also observed in smooth muscle cells (VSC) as the concentration-response curves to sodium nitroprusside were also modified. Conclusions: Our data show 1) a dose-dependent toxicity of AA on HUVECs 2) an impaired ACh-induced relaxation of aortic rings reversed by SOD, suggesting that superoxide anion is responsible for the AA-mediated endothelial dysfunction 3) some alterations in VSC but to a lesser extent than the endothelial function.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.